Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-308545
Filing Date
2014-08-13
Accepted
2014-08-13 17:00:54
Documents
15
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d745670d10q.htm 10-Q 226832
2 EX-10.2 d745670dex102.htm EX-10.2 58945
3 EX-10.3 d745670dex103.htm EX-10.3 59086
4 EX-10.4 d745670dex104.htm EX-10.4 59032
5 EX-10.5 d745670dex105.htm EX-10.5 58956
6 EX-31.1 d745670dex311.htm EX-31.1 7054
7 EX-31.2 d745670dex312.htm EX-31.2 7018
8 EX-32.1 d745670dex321.htm EX-32.1 4354
9 EX-32.2 d745670dex322.htm EX-32.2 4304
  Complete submission text file 0001193125-14-308545.txt   2826228

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT mnov-20140630.xml EX-101.INS 257031
11 XBRL TAXONOMY EXTENSION SCHEMA mnov-20140630.xsd EX-101.SCH 28870
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20140630_cal.xml EX-101.CAL 37315
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20140630_def.xml EX-101.DEF 177620
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20140630_lab.xml EX-101.LAB 261855
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20140630_pre.xml EX-101.PRE 206406
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 141038271
SIC: 2834 Pharmaceutical Preparations